Among those who have already survived one cardiac crisis, nearly half are lying awake at night — and that sleeplessness, a Norwegian study now suggests, is not merely a symptom of worry but a force quietly shaping their odds of survival. Presented at a European cardiology conference, the research followed more than a thousand heart patients over four years and found that insomnia ranked third among modifiable risk factors for recurrent cardiac events, behind only smoking and physical inactivity. The finding places something as intimate and invisible as a restless night alongside the most estab
UPI News
· Apr 08, 2022
· health
· 2 min read
High
Sourcing: Verified
Insomnia ranks third risk factor for repeat heart events in cardiac patients
Study tracked 225 major adverse cardiovascular events including heart attacks, strokes, heart failure, and cardiovascular deaths among 1,000+ cardiac patients over 4.2 years.
◉
Health & Medicine
8412 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Bias & Framing
⚖
UPI presents a straightforward medical study report on insomnia as a cardiac risk factor with minimal apparent bias, using neutral language and direct attribution.
Bias Direction
center
Confidence
HIGH
Objective medical reporting with emphasis on research findings and expert attribution. The article frames insomnia as a significant but quantifiable risk factor, presenting data-driven conclusions without sensationalism.
Limitations or criticisms of the study methodology
Alternative explanations for the correlation between insomnia and cardiac events
Perspectives from sleep medicine specialists not involved in the study
Cost-benefit analysis of insomnia screening and treatment programs
Patient experiences or quality-of-life considerations
Geopolitical Impact
🌎
This is a medical research article about insomnia as a cardiac risk factor, not a geopolitical issue.
Escalation Risk
N/A
Confidence
HIGH
Economic Lens
📈
Study identifies insomnia as third-leading risk factor for repeat cardiac events (16%), creating economic implications for healthcare costs, pharmaceutical demand, and workplace productivity losses.
Market Signal
bullish
Confidence
MED
Healthcare/Hospitals
Pharmaceutical/Sleep Medicine
Medical Devices
Insurance/Health Plans
Workplace Productivity
Mental Health Services
Cardiac patients face increased healthcare costs from insomnia screening and treatment. Consumers may experience higher insurance premiums as insurers account for sleep disorder management. Increased demand for sleep medications, cognitive behavioral therapy, and sleep monitoring devices will raise out-of-pocket costs for affected populations.
Healthcare systems may implement mandatory sleep disorder screening protocols for cardiac patients, increasing reimbursement claims. Insurance policies may expand coverage for sleep treatments. Occupational health regulations could mandate workplace sleep wellness programs. FDA may accelerate approval of sleep disorder therapeutics. Public health campaigns may promote sleep hygiene as cardiovascular prevention.